Showing 121 - 140 results of 7,766 for search '(( significant clinical decrease ) OR ( significant ((mean decrease) OR (small decrease)) ))', query time: 0.58s Refine Results
  1. 121

    Image 4_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

    Published 2024
    “…</p>Results<p>G. vaginalis inoculated mice infected with HSV-2 had significantly decreased survival rates, increased pathology, and higher viral titers than PBS and L. crispatus inoculated mice. …”
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129
  10. 130
  11. 131
  12. 132

    Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras by Charles W. Parry (20966154)

    Published 2025
    “…Activating mutations of Ras are one of the most prevalent drivers of cancer and are often associated with poor clinical outcomes. Despite FDA approval for two irreversible inhibitors that target the inactive state of KRas<sup>G12C</sup>, significant unmet clinical need still exists, and the susceptibility of non-G12C mutants to inactive-state inhibition remains unclear. …”
  13. 133
  14. 134
  15. 135
  16. 136
  17. 137
  18. 138

    Fig 1 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
  19. 139

    Fig 5 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
  20. 140